hPSC cardiomyocyte GiWi induction media
Serum-free RPMI/B27 media for temporal GSK3 and Wnt inhibition during the original GiWi cardiomyocyte protocol.
Applicable scenario
Directed differentiation of human ESCs or iPSCs into cardiomyocytes using Lian et al.'s small-molecule GiWi route. Use the tables in day order; insulin-free B27 is used through day 5 and standard B27 from day 7.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
RPMI/B27 minus insulin basal medium, 510 mL
| Component | Amount | Use |
|---|---|---|
| RPMI 1640 | 500 mL | Basal medium |
| B27 supplement Minus Insulin | 10 mL | Days 0–5 |
Day 0 · GSK3 inhibition, 24 mL
| Component | Final concentration / amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 24 mL | 2 mL per well |
| CHIR99021 | 12 µM; 8 µL of 36 mM stock | Exactly 24 h |
Day 1 · medium without small molecule
| Component | Amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 2 mL per well | Day 1 |
Day 3 · Wnt inhibition, 2 mL per well
| Component | Final concentration / amount | Timing |
|---|---|---|
| Conditioned medium | 1 mL | 72 h after CHIR99021 |
| Fresh RPMI/B27 minus insulin | 1 mL | Combine with conditioned medium |
| IWP2 | 5 µM; 2 µL of 5 mM stock | Days 3–5 |
Day 5 · medium without small molecule
| Component | Amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 2 mL per well | Day 5 |
Day 7 onward · RPMI/B27 with insulin, 510 mL
| Component | Amount | Timing |
|---|---|---|
| RPMI 1640 | 500 mL | Basal medium |
| B27 supplement | 10 mL | Day 7 and every 3 days |
Source values and calculations
- The basal recipes, 12 µM CHIR99021 and 5 µM IWP2 are reported directly in the source.
- The source recommends testing 6–14 µM CHIR99021 when a different hPSC line requires optimization.
- Day 3 uses 1 mL conditioned medium plus 1 mL fresh medium and 2 µL of 5 mM IWP2 per well; this is not a full-medium replacement.
Literature source
Lian X et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nature Protocols 8, 162–175 (2013).
Source locator: Reagent setup, RPMI/B27 media; Procedure, Cardiac differentiation with Gsk3 inhibitor and Wnt inhibitor (GiWi protocol), steps 51–57
Read the original source · DOI: 10.1038/nprot.2012.150
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.